Vaccine protection in transplant recipients
Part of Blood & lymphatic, Immune system & allergy, Infections clinical trials.
This study looks at how well vaccines work in people who have received a bone marrow or solid organ transplant. Researchers will track infections and outcomes to understand vaccine effectiveness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being evaluated for a bone marrow or solid organ transplant at our hospital.
- You must be planning to receive a bone marrow or solid organ transplant.
- You cannot have already joined this study.
- You must give your permission to take part.
- You must have no medical reason that makes it unsafe to receive vaccines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people who have had a stem cell or solid organ transplant. It aims to predict who might get a serious infection and help doctors manage their care better.
This study is following people who have had a liver, kidney, heart, or lung transplant. It will look for markers in your blood that might help predict how you do in the short and long term after transplant.
This study collects information from people getting a liver transplant. It looks at bone health and mineral levels in the body to better understand how they change after transplant.
This study tests a vaccine strategy for people who are being evaluated and waiting for a liver transplant. The goal is to see how well the immune system responds and how the results are interpreted before transplant.
This trial follows people who have had a recent organ or stem cell transplant to learn more about infections and how they can be prevented. You may be asked to provide samples and information over time.
This study checks how well adults stay protected against measles after they receive a donor bone marrow transplant. It helps doctors understand measles immune status and may guide future protection for transplant recipients.
Hear when a new Vaccine Prophylaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.